HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone response to machined and resorbable blast material titanium implants: an experimental study in rabbits.

Abstract
The aim of the present study was a comparison of implants' responses to a machined surface and to a surface sandblasted with hydroxyapatite (HA) particles (resorbable blast material [RBM]). Threaded machined and RBM, grade 3, commercially pure, titanium, screw-shaped inplants were used in this study. Twenty-four New Zealand white mature male rabbits were used. The inplants were inserted into the articular femoral knee joint according to a previously described technique. Each rabbit received 2 inplants, 1 test (RBM) and 1 control (machined). A total of 48 implants (24 control and 24 test) were inserted. The rabbits were anesthetized with intramuscular injections of fluanisone (0.7 mg/ kg body weight) and diazepam (1.5 mg/kg b.wt.), and local anesthesia was given using 1 mL of 2% lidocaine/adrenalin solution. Two rabbits died in the postoperative course. Four animals were euthanatized with an overdose of intravenous pentobarbital after 1, 2, 3, and 4 weeks; 6 rabbits were euthanatized after 8 weeks. A total of 44 implants were retrieved. The specimens were processed with the Precise 1 Automated System to obtain thin ground sections. A total of 3 slides were obtained for each implant. The slides were stained with acid and basic fuchsin and toluidine blue. The slides were observed in normal transmitted light under a Leitz Laborlux microscope, and histomorphometric analysis was performed. With the machined implants, it was possible to observe the presence of bone trabeculae near the implant surface at low magnification. At higher magnification many actively secreting alkaline phosphatasepositive (ALP+) osteoblasts were observed. In many areas, a not yet mineralized matrix was present. After 4 to 8 weeks, mature bone appeared in direct contact with the implant surface, but in many areas a not yet mineralized osteoid matrix was interposed between the mineralized bone and implant surface. In the RBM implants, many ALP+ osteoblasts were present and in direct contact with the implant surface. In other areas of the implant perimeter it was possible to observe the formation of an osteoid matrix directly on the implant surface. Mature bone with few marrow spaces was present after 4 to 8 weeks. Beginning in the third week, a statistically significant difference (P < .001) was found in the bone-implant contact percentages in machined and RBM implants. It must be stressed that these results have been obtained in a passive, nonloaded situation.
AuthorsMaurizio Piattelli, Antonio Scarano, Michele Paolantonio, Giovanna Iezzi, Giovanna Petrone, Adriano Piattelli
JournalThe Journal of oral implantology (J Oral Implantol) Vol. 28 Issue 1 Pg. 2-8 ( 2002) ISSN: 0160-6972 [Print] United States
PMID12498456 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzenesulfonates
  • Coated Materials, Biocompatible
  • Coloring Agents
  • Dental Implants
  • Dental Materials
  • Rosaniline Dyes
  • Tolonium Chloride
  • basic fuchsin
  • acid fuchsin
  • Durapatite
  • Titanium
  • Alkaline Phosphatase
Topics
  • Alkaline Phosphatase (analysis)
  • Animals
  • Benzenesulfonates
  • Bone Marrow (pathology)
  • Bone Matrix (pathology)
  • Bone and Bones (pathology, physiopathology)
  • Calcification, Physiologic (physiology)
  • Coated Materials, Biocompatible (chemistry)
  • Coloring Agents
  • Dental Implants
  • Dental Materials (chemistry)
  • Dental Prosthesis Design
  • Durapatite (chemistry)
  • Femur (surgery)
  • Male
  • Microscopy, Electron, Scanning
  • Osseointegration
  • Osteoblasts (pathology)
  • Rabbits
  • Rosaniline Dyes
  • Statistics as Topic
  • Surface Properties
  • Time Factors
  • Titanium (chemistry)
  • Tolonium Chloride

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: